Emerging-market equities and currencies last week rose for a third week amid optimism over progress toward a coronavirus vaccine. Moderna and Pfizer announced promising clinical trial results just as countries from the US to Japan imposed stricter restrictions to combat rising infections. Turkeyâ€™s central bank raised interest rates, boosting the lira, while authorities in Indonesia and the Philippines unexpectedly cut borrowing costs and South Africa held rates unchanged. The following is a roundup of emerging-market news and highlights for the week through November 22: Black Friday SpecialGet 15% discount on our annual subscription!
Offer valid from 23-30 Nov 2020. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.